I invest in biotech start-up stock due to the IP and clinical trial updates. Some think Azer-Cel is worth a few billion, I think it's $1B but I've been wrong before. If you think it's $100M then you're clueless which shouldn't be a surprise as you didn't even now the purpose of Ph1 clinical trial. CF33 and especially OnCARlytics are still the key.
IMU Price at posting:
1.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)